Janney Montgomery Scott LLC
Position in ZVRA — Zevra Therapeutics, Inc.
CIK 1329948
PHILADELPHIA, PA
Position in ZVRA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,903,261
+$1,695,969 QoQ
Shares Held
272,194
+14.9% QoQ
Ownership
0.458%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 157 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. ZVRA ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in ZVRA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,903,261 | 272,194 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,207,292 | 236,834 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,817,831 | 202,883 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,746,996 | 183,701 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,261,209 | 256,664 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,101,199 | 280,534 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,480,265 | 297,394 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,117,178 | 305,069 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,120,837 | 432,824 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,828,980 | 660,169 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,476,473 | 683,431 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,250,458 | 674,369 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,666,127 | 522,770 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,908,152 | 528,755 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,267,597 | 494,030 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,991,331 | 479,380 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,137,321 | 479,220 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,761,103 | 350,120 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,490,319 | 285,915 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $2,607,175 | 279,440 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,316,085 | 258,665 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $113,160 | 12,300 | Shares | Sole | 2021-04-27 | |
| No filing history on record for this holder in this stock. | ||||||